Jiliang G. Xia

Hunan Province Key Laboratory Of Tumor Cellular And Molecular Pathology, P.R. China
Hengyang, 421001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Triptonide enhances DNA damage by inhibiting TRIP13‑mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma.

Triptonide enhances DNA damage by inhibiting TRIP13‑mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma.

Journal: International journal of oncology

Published: January 15, 2026

Role of Ferredoxin 1 (FDX1) in cancer and its therapeutic potential.

Role of Ferredoxin 1 (FDX1) in cancer and its therapeutic potential.

Journal: Cancer pathogenesis and therapy

Published: August 13, 2025

Gamma-aminobutyric acid-B receptor axis promotes proliferation and survival of multiple myeloma cells via enhancing ERK1/2 activity.

Gamma-aminobutyric acid-B receptor axis promotes proliferation and survival of multiple myeloma cells via enhancing ERK1/2 activity.

Journal: Journal of leukocyte biology

Published: July 29, 2025

Sulforaphane inhibits multiple myeloma cell-induced osteoclast differentiation and macrophage proliferation by elevating ferroportin1.

Sulforaphane inhibits multiple myeloma cell-induced osteoclast differentiation and macrophage proliferation by elevating ferroportin1.

Journal: Cancer chemotherapy and pharmacology

Published: June 27, 2024

Role of NEK2 in tumorigenesis and tumor progression.

Role of NEK2 in tumorigenesis and tumor progression.

Journal: Trends in molecular medicine

Published: April 28, 2024

Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells.

Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells.

Journal: Annals of hematology

Published: February 21, 2024

Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer.

Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer.

Journal: Journal of Cancer

Published: October 13, 2023

Diallyl disulfide synergizes with melphalan to increase apoptosis and DNA damage through elevation of reactive oxygen species in multiple myeloma cells.

Diallyl disulfide synergizes with melphalan to increase apoptosis and DNA damage through elevation of reactive oxygen species in multiple myeloma cells.

Journal: Annals of hematology

Published: August 23, 2023

The intestinal γδ T cells: functions in the gut and in the distant organs.

The intestinal γδ T cells: functions in the gut and in the distant organs.

Journal: Frontiers in immunology

Published: April 15, 2023

Proline promotes proliferation and drug resistance of multiple myeloma by downregulation of proline dehydrogenase.

Proline promotes proliferation and drug resistance of multiple myeloma by downregulation of proline dehydrogenase.

Journal: British journal of haematology

Published: October 24, 2022

Phospholipase C delta 1 inhibits WNT/β-catenin and EGFR-FAK-ERK signaling and is disrupted by promoter CpG methylation in renal cell carcinoma.

Phospholipase C delta 1 inhibits WNT/β-catenin and EGFR-FAK-ERK signaling and is disrupted by promoter CpG methylation in renal cell carcinoma.

Journal: Clinical epigenetics

Published: September 05, 2022

Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials.

Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 19, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026